Reply

Helen A. Brough; Jean Christoph Caubet; Angel Mazon; Diab Haddad; Marcel M. Bergmann; Jacqueline Wassenberg; Valentina Panetta; Rosalynd Gourgey; Suzana Radulovic; Maria Nieto; Alexandra F. Santos; Antonio Nieto; Gideon Lack; Philippe A. Eigenmann

doi:10.1016/j.jaci.2020.02.004

Reply

Helen A. Brough, Jean Christoph Caubet, Angel Mazon, Diab Haddad, Marcel M. Bergmann, Jacqueline Wassenberg, Valentina Panetta, Rosalynd Gourgey, Suzana Radulovic, Maria Nieto, Alexandra F. Santos, Antonio Nieto, Gideon Lack, Philippe A. Eigenmann

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1481-1483
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	145
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2020.02.004
State	Published - May 2020
Externally published	Yes

Access to Document

10.1016/j.jaci.2020.02.004

Cite this

@article{01530d95e1e942cf8a87e1bd7ac5bcb6,

title = "Reply",

author = "Brough, {Helen A.} and Caubet, {Jean Christoph} and Angel Mazon and Diab Haddad and Bergmann, {Marcel M.} and Jacqueline Wassenberg and Valentina Panetta and Rosalynd Gourgey and Suzana Radulovic and Maria Nieto and Santos, {Alexandra F.} and Antonio Nieto and Gideon Lack and Eigenmann, {Philippe A.}",

note = "Funding Information: Disclosure of potential conflict of interest: H. A. Brough, J.-C. Caubet, A. Mazon, D. Haddad, A. Nieto, A. F. Santos, M. Nieto, G. Lack, and P. A. Eigenmann report personal fees from ThermoScientific during the conduct of the study for travel expenses and/or lecture fees. H. A. Brough reports grants from Food Allergy Research & Education (FARE), and other fees from UK Department of Health through the National Institute for Health Research (NIHR), during the conduct of the study; and being on scientific advisory board for DBV Technologies outside the submitted work. M. M. Bergmann reports financial contribution from the M{\"u}ller-Gierok Foundation for research in clinical allergology. V. Panetta reports personal fees from Euroimmun, outside the submitted work. A. F. Santos reports grants and personal fees from the Medical Research Council, other fees from Thermo Scientific, and nonfinancial support from Buhlmann, during the conduct of the study; grants from Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID) and Asthma UK; personal fees from Thermo Scientific, Nutricia, Infomed, and Buhlmann; and other fees from the NIAID, the European Academy of Allergy and Clinical Immunology, the BSACI, the Academy of Medical Sciences, the Portuguese Society of Allergy and Clinical Immunology (SPAIC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the French Meeting of Molecular Allergology, the Swiss Society of Allergy and Clinical Immunology, the Dutch Symposium of Paediatric Allergology, the French Society of Immunology, and the GAPIC (gabinete de apoio {\`a} investiga{\c c}{\~a}o cient{\'i}fica, tecnol{\'o}gica e inova{\c c}{\~a}o) (Instituto de Medicina Molecular, Lisbon), outside the submitted work. G. Lack reports other fees from the UK Department of Health through the NIHR during the conduct of the study; personal fees and shares in DBV Technologies, and Mighty Mission Me; and personal fees from Aravax, outside the submitted work. P. A. Eigenmann reports consultancy work for DBV Technologies, Nestle, Danone, Novartis, and Abbott; payment for lectures from ALK and Abbott; royalties from Uptodate and Elsevier; shares in DBV outside the submitted work; and financial contribution from the M{\"u}ller-Gierok Foundation for research in clinical allergology. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Food Allergy Research and Education (FARE) provided funding for the UK arm of the study, and the Ulrich Muller-Gierock Foundation provided funding for the Geneva arm of the study. Thermo Scientific, Stallergenes, and Meridien Foods provided research support for all centers. This research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas? NHS Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Disclosure of potential conflict of interest: H. A. Brough, J.-C. Caubet, A. Mazon, D. Haddad, A. Nieto, A. F. Santos, M. Nieto, G. Lack, and P. A. Eigenmann report personal fees from ThermoScientific during the conduct of the study for travel expenses and/or lecture fees. H. A. Brough reports grants from Food Allergy Research & Education (FARE), and other fees from UK Department of Health through the National Institute for Health Research (NIHR), during the conduct of the study; and being on scientific advisory board for DBV Technologies outside the submitted work. M. M. Bergmann reports financial contribution from the M?ller-Gierok Foundation for research in clinical allergology. V. Panetta reports personal fees from Euroimmun, outside the submitted work. A. F. Santos reports grants and personal fees from the Medical Research Council, other fees from Thermo Scientific, and nonfinancial support from Buhlmann, during the conduct of the study; grants from Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID) and Asthma UK; personal fees from Thermo Scientific, Nutricia, Infomed, and Buhlmann; and other fees from the NIAID, the European Academy of Allergy and Clinical Immunology, the BSACI, the Academy of Medical Sciences, the Portuguese Society of Allergy and Clinical Immunology (SPAIC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the French Meeting of Molecular Allergology, the Swiss Society of Allergy and Clinical Immunology, the Dutch Symposium of Paediatric Allergology, the French Society of Immunology, and the GAPIC (gabinete de apoio ? investiga??o cient?fica, tecnol?gica e inova??o) (Instituto de Medicina Molecular, Lisbon), outside the submitted work. G. Lack reports other fees from the UK Department of Health through the NIHR during the conduct of the study; personal fees and shares in DBV Technologies, and Mighty Mission Me; and personal fees from Aravax, outside the submitted work. P. A. Eigenmann reports consultancy work for DBV Technologies, Nestle, Danone, Novartis, and Abbott; payment for lectures from ALK and Abbott; royalties from Uptodate and Elsevier; shares in DBV outside the submitted work; and financial contribution from the M?ller-Gierok Foundation for research in clinical allergology. The rest of the authors declare that they have no relevant conflicts of interest.",

year = "2020",

month = may,

doi = "10.1016/j.jaci.2020.02.004",

language = "English",

volume = "145",

pages = "1481--1483",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Reply

AU - Brough, Helen A.

AU - Caubet, Jean Christoph

AU - Mazon, Angel

AU - Haddad, Diab

AU - Bergmann, Marcel M.

AU - Wassenberg, Jacqueline

AU - Panetta, Valentina

AU - Gourgey, Rosalynd

AU - Radulovic, Suzana

AU - Nieto, Maria

AU - Santos, Alexandra F.

AU - Nieto, Antonio

AU - Lack, Gideon

AU - Eigenmann, Philippe A.

N1 - Funding Information: Disclosure of potential conflict of interest: H. A. Brough, J.-C. Caubet, A. Mazon, D. Haddad, A. Nieto, A. F. Santos, M. Nieto, G. Lack, and P. A. Eigenmann report personal fees from ThermoScientific during the conduct of the study for travel expenses and/or lecture fees. H. A. Brough reports grants from Food Allergy Research & Education (FARE), and other fees from UK Department of Health through the National Institute for Health Research (NIHR), during the conduct of the study; and being on scientific advisory board for DBV Technologies outside the submitted work. M. M. Bergmann reports financial contribution from the Müller-Gierok Foundation for research in clinical allergology. V. Panetta reports personal fees from Euroimmun, outside the submitted work. A. F. Santos reports grants and personal fees from the Medical Research Council, other fees from Thermo Scientific, and nonfinancial support from Buhlmann, during the conduct of the study; grants from Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID) and Asthma UK; personal fees from Thermo Scientific, Nutricia, Infomed, and Buhlmann; and other fees from the NIAID, the European Academy of Allergy and Clinical Immunology, the BSACI, the Academy of Medical Sciences, the Portuguese Society of Allergy and Clinical Immunology (SPAIC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the French Meeting of Molecular Allergology, the Swiss Society of Allergy and Clinical Immunology, the Dutch Symposium of Paediatric Allergology, the French Society of Immunology, and the GAPIC (gabinete de apoio à investigação científica, tecnológica e inovação) (Instituto de Medicina Molecular, Lisbon), outside the submitted work. G. Lack reports other fees from the UK Department of Health through the NIHR during the conduct of the study; personal fees and shares in DBV Technologies, and Mighty Mission Me; and personal fees from Aravax, outside the submitted work. P. A. Eigenmann reports consultancy work for DBV Technologies, Nestle, Danone, Novartis, and Abbott; payment for lectures from ALK and Abbott; royalties from Uptodate and Elsevier; shares in DBV outside the submitted work; and financial contribution from the Müller-Gierok Foundation for research in clinical allergology. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Food Allergy Research and Education (FARE) provided funding for the UK arm of the study, and the Ulrich Muller-Gierock Foundation provided funding for the Geneva arm of the study. Thermo Scientific, Stallergenes, and Meridien Foods provided research support for all centers. This research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas? NHS Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Disclosure of potential conflict of interest: H. A. Brough, J.-C. Caubet, A. Mazon, D. Haddad, A. Nieto, A. F. Santos, M. Nieto, G. Lack, and P. A. Eigenmann report personal fees from ThermoScientific during the conduct of the study for travel expenses and/or lecture fees. H. A. Brough reports grants from Food Allergy Research & Education (FARE), and other fees from UK Department of Health through the National Institute for Health Research (NIHR), during the conduct of the study; and being on scientific advisory board for DBV Technologies outside the submitted work. M. M. Bergmann reports financial contribution from the M?ller-Gierok Foundation for research in clinical allergology. V. Panetta reports personal fees from Euroimmun, outside the submitted work. A. F. Santos reports grants and personal fees from the Medical Research Council, other fees from Thermo Scientific, and nonfinancial support from Buhlmann, during the conduct of the study; grants from Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID) and Asthma UK; personal fees from Thermo Scientific, Nutricia, Infomed, and Buhlmann; and other fees from the NIAID, the European Academy of Allergy and Clinical Immunology, the BSACI, the Academy of Medical Sciences, the Portuguese Society of Allergy and Clinical Immunology (SPAIC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the French Meeting of Molecular Allergology, the Swiss Society of Allergy and Clinical Immunology, the Dutch Symposium of Paediatric Allergology, the French Society of Immunology, and the GAPIC (gabinete de apoio ? investiga??o cient?fica, tecnol?gica e inova??o) (Instituto de Medicina Molecular, Lisbon), outside the submitted work. G. Lack reports other fees from the UK Department of Health through the NIHR during the conduct of the study; personal fees and shares in DBV Technologies, and Mighty Mission Me; and personal fees from Aravax, outside the submitted work. P. A. Eigenmann reports consultancy work for DBV Technologies, Nestle, Danone, Novartis, and Abbott; payment for lectures from ALK and Abbott; royalties from Uptodate and Elsevier; shares in DBV outside the submitted work; and financial contribution from the M?ller-Gierok Foundation for research in clinical allergology. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2020/5

Y1 - 2020/5

UR - http://www.scopus.com/inward/record.url?scp=85083666390&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2020.02.004

DO - 10.1016/j.jaci.2020.02.004

M3 - Letter

C2 - 32223981

AN - SCOPUS:85083666390

SN - 0091-6749

VL - 145

SP - 1481

EP - 1483

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -